NAIROBI, Kenya, Oct 7— The World Health Organization (WHO) has issued its first global guidelines for treating obesity in children and adolescents as the number of young people living with the disease has quadrupled since 1990. Breaking It Down WHO estimates that obesity now affects around 8 per cent of children and adolescents aged five to 19, up from 2 per cent three decades ago. In 2024, about 170 million children and adolescents were living
10/07/26 • 3 Views
NAIROBI, Kenya, Oct 7— The World Health Organization (WHO) has issued its first global guidelines for treating obesity in children and adolescents as the number of young people living with the disease has quadrupled since 1990.
📻 Breaking It Down
WHO estimates that obesity now affects around 8 per cent of children and adolescents aged five to 19, up from 2 per cent three decades ago.
In 2024, about 170 million children and adolescents were living with obesity, including 70 million children aged five to nine and around 100 million adolescents.
The UN health agency is urging countries to prioritise comprehensive lifestyle support, including healthier diets, physical activity and sustained behaviour change, while reserving medicines and surgery for carefully selected older adolescents.
📌 What You Need to Know
“The foundation of obesity care for children and adolescents is not medicine or surgery, but access to comprehensive support that enables healthy eating, physical activity and sustainable behaviour change,” said Dr Luz María De Regil, Director of WHO’s Department of Nutrition and Food Safety.
WHO classifies obesity as a chronic, relapsing disease caused by excessive accumulation of body fat that can be managed through appropriate care.
The agency warned that obesity during childhood can have lifelong consequences, increasing the risk of conditions including type 2 diabetes and cardiovascular disease.
Children and adolescents living with obesity may also face stigma, discrimination and bullying, which can damage their mental health and contribute to anxiety, depression and low self-esteem.
WHO does not recommend weight-loss medicines, bariatric surgery or weight-loss devices for children aged 0 to 9.
For adolescents aged 10 to 19, approved obesity medicines, including GLP-1 therapies, should only be considered when a supervised lifestyle programme has failed to produce sufficient improvement.
📰 Source: Capital FM Kenya






